24.12.2012 Views

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Topic 8: Mucosal Immunity<br />

P08.19 LB<br />

A Novel Mechanism of <strong>HIV</strong> Transcytosis and Infection<br />

S. Gupta 1 , J.C. Becerra 1 , D.N. Forthal 1<br />

1 University of California Irvine, Irvine, CA, USA<br />

Background: Female genital tract mucosae are bathed in acidic<br />

secretions, which, in the case of <strong>HIV</strong>-1 infected women, likely<br />

contain virus coated with antibody. Thus, uninfected male sexual<br />

partners are often exposed to an acidic milieu containing virus in<br />

the form of immune complexes. We investigated the impact of low<br />

pH and antibody on transcytosis, a potentially critical mechanism<br />

by which <strong>HIV</strong>-1 passes through genital tract epithelia to infect<br />

susceptible target cells.<br />

Methods: <strong>HIV</strong>-1 was incubated with Env-specific monoclonal<br />

and polyclonal antibodies at pH 6.0 or pH 7.4 and exposed to<br />

the apical surface of tight junction-forming human endometrial<br />

carcinoma (HEC-1) cells in transwell plates. The quantity and<br />

infectivity of transcytosed virus was measured by RT-PCR and<br />

infection of TZMbl cells, respectively.<br />

Results: We found that the combination of acidic pH and Envspecific<br />

antibody augmented transcytosis as much as 30-fold<br />

compared with Env-specific antibody at neutral pH or compared<br />

with non-specific antibody or no antibody at neutral or acidic pH.<br />

The pH and antibody dependence of enhanced transcytosis was<br />

blocked by antibody specific for the Fc neonatal receptor (FcRn)<br />

or by treatment with bafilomycin A1 (which inhibits acidification<br />

of endosomes). Non-neutralizing antibodies resulted in a lower<br />

quantity of total transcytosed virus, measured by RT-PCR, than did<br />

neutralizing antibodies. However, the ratio of total to infectious<br />

virus was much higher for neutralizing antibodies, indicating<br />

that neutralizing antibodies efficiently allow transcytosis while<br />

blocking infectivity of the transcytosed virus; the non-neutralizing<br />

antibodies facilitate transcytosis (although to a lesser degree<br />

than the neutralizing antibodies) without blocking infectivity.<br />

Conclusion: These results demonstrate that acidity and Envspecific<br />

antibody greatly enhance transcytosis of virus across<br />

mucosal epithelial cells via FcRn. Since male penile and urethral<br />

tissues express FcRn, our results suggest a novel mechanism by<br />

which antibody, and in particular, non-neutralizing antibody, might<br />

facilitate female-to-male transmission following sexual exposure.<br />

P08.20 LB<br />

AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />

Posters<br />

Influence of Hormones and <strong>HIV</strong> Infection on Viral<br />

Transport<br />

D.J. Stieh 1 , S.A. Allan 1 , S.A. Shukair 1 , G.C. Cianci 1 , A.J. Fought 1 ,<br />

A. French 2 , T.J. Hope 1<br />

1 Northwestern University, Chicago, IL, USA; 2 Ruth M. Rothstein<br />

CORE Center, Chicago, IL, USA<br />

Background: Inhibiting transport of virions within the female<br />

reproductive tract is an attractive mechanism for transmission<br />

prevention. The mucosal environment varies with menstrual<br />

cycle and concurrent bacterial vaginosis (BV). Previous studies<br />

of transport within mucosal samples have focused on cervicovaginal<br />

samples in exclusion. Severe BV corresponds to increased<br />

incidence of female-to-male <strong>HIV</strong>-1 transmission although the<br />

mechanism remains unclear.<br />

Methods: We have established a cohort of <strong>HIV</strong> +ve and –ve women<br />

to be longitudinally studied for correlates of inhibited transport<br />

phenotypes. Cervical and cervico-vaginal mucus samples (CM and<br />

CVM, respectively) are collected, along with mucosal antibodies,<br />

vaginal smears, hormone levels, viral load, T cell monitoring panels<br />

as well as medical and behavioral history. Viral transport assays<br />

employ a diverse panel of viral isolates, testing clade specific<br />

effects. As of this interim analysis, over 60 study subjects have<br />

been recruited and repeat sampling is beginning.<br />

Results: The hormone profile demarcating menstrual cycle<br />

phase correlates strongly with particle movement. In CVM, the<br />

nature of viral interactions with their environment changes;<br />

lowest progesterone to estradiol ratio corresponds with<br />

hindered diffusion. Non-reactive similarly sized PEGylated beads<br />

have freely diffusive behavior throughout the menstrual cycle.<br />

Cycle classification into follicular, mid-cycle and luteal periods<br />

demonstrates that CVM in the luteal phase is, unexpectedly, most<br />

permissive to viral transport. Severe BV has modest effects on pH<br />

of CVM and no effect on CM. This is reflected in viral transport<br />

characteristics whereby the magnitude and nature of movement<br />

is invariant during severe BV relative to healthy flora.<br />

Conclusion: It is unlikely that the mechanisms of increased<br />

transmission with BV are related to virus diffusing more freely<br />

within mucus. Correlates of hindered diffusion are not restricted<br />

to adaptive immune responses. This study begins to reveal the<br />

significance of immune correlates and hormone profiles on<br />

<strong>HIV</strong>-1 transmission mechanisms and transport in the female<br />

reproductive tract.<br />

199<br />

POSTERS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!